000 01509 a2200433 4500
005 20250513043802.0
264 0 _c19950803
008 199508s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/0006-8993(95)00007-d
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGordon, I
245 0 0 _a[3H]GBR 12935 labels mainly the piperazine acceptor site in the rat prefrontal cortex.
_h[electronic resource]
260 _bBrain research
_cMar 1995
300 _a205-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
_xdrug effects
650 0 4 _aCarrier Proteins
_xmetabolism
650 0 4 _aDopamine Antagonists
_xpharmacology
650 0 4 _aDopamine Plasma Membrane Transport Proteins
650 0 4 _aFlupenthixol
_xpharmacology
650 0 4 _aKinetics
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMazindol
_xpharmacology
650 0 4 _aMembrane Glycoproteins
650 0 4 _aMembrane Transport Proteins
650 0 4 _aNeostriatum
_xdrug effects
650 0 4 _aNerve Tissue Proteins
_xmetabolism
650 0 4 _aPiperazines
_xantagonists & inhibitors
650 0 4 _aPrefrontal Cortex
_xdrug effects
650 0 4 _aRats
650 0 4 _aSodium
_xphysiology
700 1 _aWeizman, R
700 1 _aRehavi, M
773 0 _tBrain research
_gvol. 674
_gno. 2
_gp. 205-10
856 4 0 _uhttps://doi.org/10.1016/0006-8993(95)00007-d
_zAvailable from publisher's website
999 _c7795455
_d7795455